MARKET

XOMAO

XOMAO

XOMA Royalty Corporation
NASDAQ
25.42
+0.04
+0.16%
After Hours: 25.44 +0.02 +0.08% 16:10 06/12 EDT
OPEN
25.43
PREV CLOSE
25.38
HIGH
25.44
LOW
25.42
VOLUME
7.24K
TURNOVER
--
52 WEEK HIGH
26.40
52 WEEK LOW
23.17
MARKET CAP
44.75M
P/E (TTM)
15.40
1D
5D
1M
3M
1Y
5Y
1D
XOMA Corp - 8.375% DP PFD B declares $0.5234 dividend
Seeking Alpha · 17h ago
Weekly Report: what happened at XOMAO last week (0601-0605)?
Weekly Report · 5d ago
Weekly Report: what happened at XOMAO last week (0525-0529)?
Weekly Report · 06/01 09:38
Saying Goodbye To The XOMA Royalty PFDs
Seeking Alpha · 05/25 12:00
Weekly Report: what happened at XOMAO last week (0518-0522)?
Weekly Report · 05/25 09:40
XOMA Royalty shareholders approve 2026 employee stock purchase plan with 500,000 shares
PUBT · 05/22 10:05
XOMA Royalty amends Ligand merger deal to add HoldCo as party
PUBT · 05/18 13:12
Weekly Report: what happened at XOMAO last week (0511-0515)?
Weekly Report · 05/18 09:40
More
About XOMAO
XOMA Royalty Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to funded partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The Company's commercial assets include OJEMDA (tovorafenib), IXINITY, XACIATO, VABYSMO (faricimab svoa), DSUVIA (sufentanil sublingual tablet), and MIPLYFFA (arimoclomol). Its Phase III assets include Rilvegostomig (AZD2936), Ficlatuzumab (AV-299), Ovaprene, D-Fi (FCX-007), Seralutinib, Cetrelimab (JNJ-63723283), Ersodetug (RZ358), and Mezagitamab (TAK-079). Its Phase II assets include Acimtamig (AFM13), AFM24, Vosaroxin, Aldoxorubicin, G03-52-01, PBF-680, PBF-677, Vidutolimod (CMP-001), and RZ-402. Its others assets include COM902 and MT-0169.

Webull offers XOMA Royalty Corp stock information, including NASDAQ: XOMAO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XOMAO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XOMAO stock methods without spending real money on the virtual paper trading platform.